food ingredients 1st
Debut Biotech lands US$22.6M to commercialize cell-free biomanufacturing ingredients
Debut Biotech, a biomanufacturing platform harnessing cell-free enzymes, has raised US$22.6 million in series A financing, led by Material Impact, a US-based venture firm.
Food Dive
Debut Biotech partners with DIC to develop natural colors for food
Debut claims its platform can overcome some of the existing barriers to creating all-natural and biodegradable pigments. The obstacles include low yields, post-extraction waste generation and environmental burdens, such as land and water use, that come from using flowers and plants to extract pigments. Volatile weather also can impact output and quality.
Genetic Engineering & Biotechnology News
Debut Biotech Raises $22.6M Series A Financing
Debut Biotech officials say that in addition to producing rare, high-value, and novel compounds, the company’s technology also improves traditional ingredient manufacturing.
Fierce Biotech
Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility
Two-year-old biomanufacturing upstart Debut Biotech, led by CEO Joshua Britton, has already inked partnerships with Battelle, DSM and DIC.
